KBLB — Kraig Biocraft Laboratories Balance Sheet
0.000.00%
- $132.91m
- $137.74m
- 33
- 62
- 72
- 56
Annual balance sheet for Kraig Biocraft Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.125 | 0.817 | 2.36 | 3.96 | 2.55 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.157 | 0.82 | 2.37 | 3.98 | 2.57 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.591 | 0.454 | 0.215 | 0.147 | 0.162 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 0.751 | 1.28 | 3.02 | 4.57 | 3.23 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 5.58 | 7.45 | 8.16 | 8.07 | 8.89 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 6.14 | 7.85 | 8.32 | 8.09 | 8.94 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -5.39 | -6.57 | -5.3 | -3.52 | -5.71 |
Total Liabilities & Shareholders' Equity | 0.751 | 1.28 | 3.02 | 4.57 | 3.23 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |